Trupanion price to free cash flow TRUP

Market value divided by free cash flow over the last twelve months, since 2017.

Today, Oct 23, 2026: 15.7×
10-year median: 106×
Against its 10-year history: 9th; percentile: 0 is its lowest day, 100 its highest
10-year range: 12.4× to 476×
Peer median: 16.4×

Trupanion's price to free cash flow is 15.7× as of Oct 23, 2026.

That is below its ten-year median of 106×, lower than on 91% of days in the last ten years.

Over that time it ranged from 12.4× in Sep 2026 to 476× in Jun 2021.

The median for 10 healthcare stocks of a similar size is 16.4×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	15.7×	12.4×	22.4×
2025	22.7×	21.2×	69.4×
2024	69.6×	69.6×	137×
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	476×	212×	476×
2020	269×	77.3×	319×
2019	120×	104×	121×
2018	246×	120×	388×
2017	117×	78.2×	157×

Against its peers

Companies in Healthcare nearest Trupanion's size, closest first, today.

Company	Price to free cash flow
TRUPTrupanion	15.7×
CDRECadre	16.4×
BVSBioventus	13.3×
USPHU S Physical Therapy	20.6×
OMEROmeros	n/m
HLFHerbalife	4.4×
OMDAOmada Health	51.0×
PCRXPacira BioSciences	8.1×
ANABAnaptysbio	n/m
STAAStaar Surgical	n/m
PNTGPennant	42.2×
Peer median	16.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Trupanion

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.